NCT04708470 2025-12-31A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon CancersNational Institutes of Health Clinical Center (CC)Phase 1/2 Active not recruiting55 enrolled